Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy
CompletedNCT00803556
Bristol-Myers SquibbBreast Cancer, Solid Tumor
Start: 2006-01-31End: 2009-08-31Updated: 2011-06-27